Skip to main content
Erschienen in: Obesity Surgery 12/2017

17.07.2017 | Original Contributions

Estimated Costs of Clinical and Surgical Treatment of Severe Obesity in the Brazilian Public Health System

verfasst von: Paula Rosales Zubiaurre, Luciana Ribeiro Bahia, Michelle Quarti Machado da Rosa, Roberto Pereira Assumpção, Alexandre Vontobel Padoin, Samanta Pereira Sussembach, Everton Nunes da Silva, Claudio Corá Mottin

Erschienen in: Obesity Surgery | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Obesity is a major global epidemic and a burden to society and health systems. This study aimed to estimate and compare the anual costs of clinical and surgical treatment of severe obesity from the perspective of the Brazilian Public Health System.

Methods

An observational and cross-sectional study was performed in three reference centers. Data collection on health resources utilization and productivity loss was carried out through an online questionnaire. Participants were divided in clinical (waiting list for a bariatric surgery) and surgical groups (open Roux-en-Y gastric bypass), and then allocated by the time of surgery (up to 1 year; 1–2 years; 2–3 years; and >3 years). Costs of visits, medications, exams, and surgeries were obtained from government sources. Data on non-medical costs, such as transportation, special diets, and caregivers, were also colleted. Productivity loss was estimated using self-reported income. Costs in local currency (Real) were converted to international dollars (Int$ 2015).

Results

Two hundred and seventy-four patients, 140 in surgical group and 134 in clinical group were included. In first postoperative year, the surgical group had higher costs than clinical group (Int$6005.47 [5000.18–8262.36] versus 2148.14 [1412.2–3506.8]; p = 0.0002); however, from the second year, the costs decreased progressively. In the same way, indirect costs decreased significantly after surgery (259.08 [163.63–662.72] versus 368.17 [163.62–687.27]; p = 0.06).

Conclusion

Total costs were higher in the surgical group in the first 2 years after surgery. However, from the third year on, the costs were lower than in the clinical group.
Literatur
1.
Zurück zum Zitat NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377–96.CrossRef NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377–96.CrossRef
4.
Zurück zum Zitat Bahia L, Coutinho ES, Barufaldi LA, et al. The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study. BMC Public Health. 2012;12:440.CrossRefPubMedPubMedCentral Bahia L, Coutinho ES, Barufaldi LA, et al. The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study. BMC Public Health. 2012;12:440.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Lemstra M, Bird Y, Nwankwo C, et al. Weight loss intervention adherence and factors promoting adherence: a meta-analysis. Patient Prefer Adherence. 2016;10:1547–59.CrossRefPubMedPubMedCentral Lemstra M, Bird Y, Nwankwo C, et al. Weight loss intervention adherence and factors promoting adherence: a meta-analysis. Patient Prefer Adherence. 2016;10:1547–59.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Machado IC, Kirsten VR. Adesão ao tratamento nutricional de pacientes adultos atendidos em uma clínica de Santa Maria – RS. Disc Scientia. 2011;12(1):81–91. Machado IC, Kirsten VR. Adesão ao tratamento nutricional de pacientes adultos atendidos em uma clínica de Santa Maria – RS. Disc Scientia. 2011;12(1):81–91.
7.
Zurück zum Zitat Khera R, Murad MH, Chandar AK, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424–34.CrossRefPubMedPubMedCentral Khera R, Murad MH, Chandar AK, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424–34.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–190. 215-357 iii-ivCrossRef Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–190. 215-357 iii-ivCrossRef
9.
Zurück zum Zitat Silva CF, Cohen L, Sarmento LD, et al. Effects of long-term Roux-En-Y gastric bypass on body weight and clinical metabolic comorbidities in bariatric surgery service of a university hospital. Arq Bras Cir Dig. 2016;29(Suppl 1):20–3.CrossRefPubMedCentral Silva CF, Cohen L, Sarmento LD, et al. Effects of long-term Roux-En-Y gastric bypass on body weight and clinical metabolic comorbidities in bariatric surgery service of a university hospital. Arq Bras Cir Dig. 2016;29(Suppl 1):20–3.CrossRefPubMedCentral
10.
Zurück zum Zitat Wu GZ, Cai B, Yu F, et al. Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus. Oncotarget. 2016;7(52):87511–22.PubMedPubMedCentral Wu GZ, Cai B, Yu F, et al. Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus. Oncotarget. 2016;7(52):87511–22.PubMedPubMedCentral
11.
Zurück zum Zitat Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.CrossRefPubMed Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.CrossRefPubMed
12.
Zurück zum Zitat Eliasson B, Liakopoulos V, Franzén S, et al. Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study. Lancet Diabetes Endocrinol. 2015;3(11):847–54.CrossRefPubMed Eliasson B, Liakopoulos V, Franzén S, et al. Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study. Lancet Diabetes Endocrinol. 2015;3(11):847–54.CrossRefPubMed
14.
Zurück zum Zitat Conselho Federal de Medicina (BR). Entidades de Fiscalização do Exercício das Profissões Liberais: retificação. DOU. 2016 Jan 29;Seção 1:287 Conselho Federal de Medicina (BR). Entidades de Fiscalização do Exercício das Profissões Liberais: retificação. DOU. 2016 Jan 29;Seção 1:287
16.
Zurück zum Zitat Agência Nacional de Vigilância Sanitária. Câmara de Regulação do Mercado de Medicamentos—CMED. Secretaria Executiva. Preços máximos de medicamentos por princípio ativo [Internet]: preço fábrica—PF (preço para laboratórios e distribuidores) preço máximo ao consumidor—PMC (preço para farmácias e drogarias). [cited 2016 Aug 22]. Available at: http://portal.anvisa.gov.br/listas-de-precos Agência Nacional de Vigilância Sanitária. Câmara de Regulação do Mercado de Medicamentos—CMED. Secretaria Executiva. Preços máximos de medicamentos por princípio ativo [Internet]: preço fábrica—PF (preço para laboratórios e distribuidores) preço máximo ao consumidor—PMC (preço para farmácias e drogarias). [cited 2016 Aug 22]. Available at: http://​portal.​anvisa.​gov.​br/​listas-de-precos
22.
Zurück zum Zitat Cremieux PY, Buchwald H, Shikora SA, et al. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008;14(9):589–96.PubMed Cremieux PY, Buchwald H, Shikora SA, et al. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008;14(9):589–96.PubMed
23.
Zurück zum Zitat Neovius M, Narbro K, Keating C, et al. Health care use during 20 years following bariatric surgery. JAMA. 2012;308(11):1132–41.CrossRefPubMed Neovius M, Narbro K, Keating C, et al. Health care use during 20 years following bariatric surgery. JAMA. 2012;308(11):1132–41.CrossRefPubMed
24.
Zurück zum Zitat Hoque ME, Mannan M, Long KZ, et al. Economic burden of underweight and overweight among adults in the Asia-Pacific region: a systematic review. Tropical Med Int Health. 2016;21(4):458–69.CrossRef Hoque ME, Mannan M, Long KZ, et al. Economic burden of underweight and overweight among adults in the Asia-Pacific region: a systematic review. Tropical Med Int Health. 2016;21(4):458–69.CrossRef
25.
26.
Zurück zum Zitat Lal A, Moodie M, Ashton T, et al. Health care and lost productivity costs of overweight and obesity in New Zealand. Aust N Z J Public Health. 2012;36(5):550–6.CrossRefPubMed Lal A, Moodie M, Ashton T, et al. Health care and lost productivity costs of overweight and obesity in New Zealand. Aust N Z J Public Health. 2012;36(5):550–6.CrossRefPubMed
27.
Zurück zum Zitat Pitayatienanan P, Butchon R, Yothasamut J, et al. Economic costs of obesity in Thailand: a retrospective cost-of-illness study. BMC Health Serv Res. 2014;14:146.CrossRefPubMedPubMedCentral Pitayatienanan P, Butchon R, Yothasamut J, et al. Economic costs of obesity in Thailand: a retrospective cost-of-illness study. BMC Health Serv Res. 2014;14:146.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Sussenbach SP, Padoin AV, Silva EN, et al. Economic benefits of bariatric surgery. Obes Surg. 2012;22(2):266–70.CrossRefPubMed Sussenbach SP, Padoin AV, Silva EN, et al. Economic benefits of bariatric surgery. Obes Surg. 2012;22(2):266–70.CrossRefPubMed
29.
Zurück zum Zitat Keating CL, Moodie ML, Bulfone L, et al. Healthcare utilization and costs in severely obese subjects before bariatric surgery. Obesity (Silver Spring). 2012;20(12):2412–9.CrossRef Keating CL, Moodie ML, Bulfone L, et al. Healthcare utilization and costs in severely obese subjects before bariatric surgery. Obesity (Silver Spring). 2012;20(12):2412–9.CrossRef
30.
Zurück zum Zitat Gesquiere I, Aron-Wisnewsky J, Foulon V, et al. Medication cost is significantly reduced after Roux-en-Y gastric bypass in obese patients. Obes Surg. 2014;24(11):1896–903.CrossRefPubMed Gesquiere I, Aron-Wisnewsky J, Foulon V, et al. Medication cost is significantly reduced after Roux-en-Y gastric bypass in obese patients. Obes Surg. 2014;24(11):1896–903.CrossRefPubMed
31.
Zurück zum Zitat Xavier DB, Ramalho WM, da Silva EN. Spending on bariatric surgery in the unified health system from 2010 to 2014: a study based on the specialist hospitals authorized by the Ministry of Health. Obes Surg. 2016;13 [Epub ahead of print] Xavier DB, Ramalho WM, da Silva EN. Spending on bariatric surgery in the unified health system from 2010 to 2014: a study based on the specialist hospitals authorized by the Ministry of Health. Obes Surg. 2016;13 [Epub ahead of print]
Metadaten
Titel
Estimated Costs of Clinical and Surgical Treatment of Severe Obesity in the Brazilian Public Health System
verfasst von
Paula Rosales Zubiaurre
Luciana Ribeiro Bahia
Michelle Quarti Machado da Rosa
Roberto Pereira Assumpção
Alexandre Vontobel Padoin
Samanta Pereira Sussembach
Everton Nunes da Silva
Claudio Corá Mottin
Publikationsdatum
17.07.2017
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 12/2017
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-2776-5

Weitere Artikel der Ausgabe 12/2017

Obesity Surgery 12/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.